The CNS penetrating taxane TPI 287 and the AURKA inhibitor alisertib induce synergistic apoptosis in glioblastoma cells CT Zumbar, A Usubalieva, PD King, X Li, CS Mifsud, HM Dalton, M Sak, ... Journal of Neuro-oncology 137, 481-492, 2018 | 21 | 2018 |
Cytotoxic synergy between alisertib and carboplatin versus alisertib and irinotecan are inversely dependent on MGMT levels in glioblastoma cells M Sak, CT Zumbar, PD King, X Li, CS Mifsud, A Usubalieva, CD Anderson, ... Journal of Neuro-oncology 143, 231-240, 2019 | 10 | 2019 |
The CNS-penetrating taxane drug TPI 287 potentiates antiglioma activity of the AURKA inhibitor alisertib in vivo M Sak, BJ Williams, CT Zumbar, L Teer, MNG Al-Kawaaz, A Kakar, ... Cancer Chemotherapy and Pharmacology 91 (2), 191-201, 2023 | 3 | 2023 |
Astroblastomas exhibit radial glia stem cell lineages and differential expression of imprinted and X-inactivation escape genes NL Lehman, N Spassky, M Sak, A Webb, CT Zumbar, A Usubalieva, ... Nature Communications 13 (1), 2083, 2022 | 3 | 2022 |
EXTH-22. The CNS penetrating taxane TPI 287 and the aurka inhibitor alisertib improve survival in vivo B Williams, C Zumbar, M Sak, N Lehman Neuro-Oncology 22 (Suppl 2), ii91, 2020 | 2 | 2020 |
Author Correction: Astroblastomas exhibit radial glia stem cell lineages and differential expression of imprinted and X-inactivation escape genes NL Lehman, N Spassky, M Sak, A Webb, CT Zumbar, A Usubalieva, ... nature communications 14, 2023 | 1 | 2023 |
Aurora-A kinase is differentially expressed in the nucleus and cytoplasm in normal Müllerian epithelium and benign, borderline and malignant serous ovarian neoplasms KJ Alkhateeb, JE Crane, M Sak, CJ Jorgensen, JP O’Donnell, CT Zumbar, ... Diagnostic Pathology 16, 1-8, 2021 | 1 | 2021 |
EXTH-75. The aurora kinase A inhibitor alisertib is synergistic with irinotecan and carboplatin against glioblastoma cells E Burton, C Zumbar, P King, M Sak, A Usubalieva, X Li, C Mifsud, ... Neuro-Oncology 20 (Suppl 6), vi101, 2018 | 1 | 2018 |
EXTH-46. ALISERTIB POTENTIATES THE EFFECT OF CABOZANTINIB AND VANDETANIB AGAINST GLIOBLASTOMA CELLS B Williams, C Zumbar, C Mifsud, K Smith, M Sak, N Lehman Neuro-Oncology 21 (Suppl 6), vi92, 2019 | | 2019 |
Aurora-A inhibitor alisertib potentiates VEGFR inhibitors in glioblastoma cell lines K Smith, C Mifsud, C Zumbar, N Lehman ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 257, 2019 | | 2019 |
The AURKA Inhibitor Alisertib Is Synergistic With Irinotecan And Carboplatin Against Glioblastoma Cells C Zumbar, P King, M Sak, A Usubalieva, X Li, C Mifsud, J McElroy, ... JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 77 (6), 491-492, 2018 | | 2018 |